Skip to content
Clinical ResearchResearch compound

DHEA (Dehydroepiandrosterone)

Natural adrenal hormone: a supplement in the United States, a medicine in the EU; barely raises testosterone in young men.

Available at
DEUSPOWER logo
DEUSPOWERProduct page

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

DHEA (Dehydroepiandrosterone) vial

Related comparisons

Pregnenolone vs DHEA

DETAILED OVERVIEW

What is DHEA (Dehydroepiandrosterone)?

DHEA (dehydroepiandrosterone) is a natural hormone of the adrenal glands, from which the body can form both testosterone and estrogen. In the United States it is a freely sold dietary supplement, while in the European Union (including Hungary) it is a prescription medicine, used for adrenal insufficiency and for male-hormone deficiency after menopause. Bodybuilders also take it to support testosterone levels, but its value is disputed.

Only a few smaller studies have been done in humans: in older men with low DHEA levels it raised testosterone slightly, but it also raised estradiol (an estrogen) by about 15–20%. In young, healthy men the testosterone rise is minimal or absent, while the side effects remain: hair loss, breast growth and water retention. In women it can cause a deeper voice and more body hair. It must not be used with hormone-sensitive cancers such as prostate or breast cancer, or in pregnancy. In competitive sport it is banned both in and out of competition.

Mechanism

A hormone of the adrenal gland; can convert to testosterone and estrogen

Half-life

DHEA itself about 25 minutes; its sulfate form about 10 hours

Onset

Sulfate form rises in 1–2 hours; hormone effect after 2–4 weeks

Legal status

US: dietary supplement; Hungary: prescription only; on the doping ban list

Data console

Lab data

Androgenic:AnabolicN/A (endogenous precursor steroid, NOT an exogenous AAS – peripheral conversion toward Test/DHT/E2)
AR bindingDHEA alone has weak AR-affinity…
Active half-life~10 hours (DHEA-S sulfate-conjugated active metabolite – the clinically measured stable form)
Detection windowWADA-accredited LC-MS/MS urine detection 7-14 days post-last-dose. T/E (testosterone/epitestosterone) ratio + DHEA-S/DHEA ratio monitoring – elevated DHEA-S ratio raises exogenous supplementation suspicion.
AromatizationAromatizes – DHEA → androstenedione → Test → E2 peripheral conversion via CYP19A1 aromatase. Magnitude moderate: E2 rise ~15-20% over baseline, gyno-sensitive users may justify AI co-administration (Aromasin 12.5 mg EOD). Aromatase-rich tissues (adipose, liver) are the primary conversion sites.
HepatotoxicityLow hepatic burden at oral dose <50 mg/day. Chronic high-dose (>50 mg/day >6 months) protocols show hepatic enzyme rise (ALT/AST) as rare-but-documented in FDA Cellgevity OTC monograph supplement adverse-event reports. ALT/AST monitoring every 8-12 weeks on chronic dosing.

Safety

Side effects, stop signs, contraindications

Side effects · 8

  • Androgenic effects (acne, oily skin, male-pattern hair loss) from peripheral DHEA to testosterone/DHT conversion in susceptible individuals.
  • Virilization in women: voice deepening, hirsutism, clitoral enlargement, menstrual irregularity, because conversion has relatively greater effect on a woman's lower androgen baseline.
  • Estrogenic effects via aromatization: roughly 15-20% E2 rise, which can provoke gynecomastia and water retention in gyno-sensitive men.
  • Adverse lipid changes: moderate, dose-dependent decrease in HDL cholesterol with chronic use.
  • Prostate effect in men over 50: DHT conversion may theoretically drive prostate growth and PSA rise, so PSA monitoring is warranted.
  • Hepatic enzyme elevation (ALT/AST) is rare but documented with chronic high doses (over 50 mg/day for over 6 months); at low oral doses (under 50 mg/day) liver burden is minimal.
  • Symptoms of hormonal imbalance: irritability, sleep disturbance, breast tenderness, and menstrual disruption in women.
  • In young men with normal hormone levels, there is minimal or no testosterone increase while aromatization risk persists, making the risk-benefit ratio unfavorable.

Contraindications · 7

  • Hormone-sensitive cancers (prostate, breast, uterine, ovarian) or suspicion thereof: absolute contraindication, because DHEA converts toward androgens/estrogens.
  • Active prostate disease: severe benign prostatic hyperplasia (BPH, Qmax under 10 mL/s) or elevated PSA, due to DHT-mediated growth risk.
  • Pregnancy and breastfeeding: absolute contraindication due to risk of fetal/infant androgen exposure.
  • Competitive, drug-tested athletes: listed on WADA S1.1.b (endogenous anabolic androgens), banned in and out of competition; detectable in urine for 7-14 days.
  • Predisposition to gynecomastia or prior gyno history without an aromatase inhibitor: the E2 rise can trigger symptoms; higher body fat (adipose aromatase) increases the risk.
  • Pre-existing liver disease or unfavorable lipid profile (low HDL): chronic high doses can further worsen enzyme and lipid values, avoid without monitoring.
  • Young user with normal hormone levels and no endocrine indication: benefit is minimal and hormonal side effects are disproportionate; in the EU (HU) it is in any case prescription-only.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about DHEA (Dehydroepiandrosterone)?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.